Show simple item record

dc.contributor.authorAllen, Nicola
dc.contributor.authorLiberti, Lawrence
dc.contributor.authorWalker, Stuart R.
dc.contributor.authorSalek, Sam
dc.date.accessioned2019-08-21T15:07:24Z
dc.date.available2019-08-21T15:07:24Z
dc.date.issued2017-06-30
dc.identifier.citationAllen , N , Liberti , L , Walker , S R & Salek , S 2017 , ' A comparison of reimbursement recommendations by European HTA agencies : Is there opportunity for further alignment? ' , Frontiers in Pharmacology , vol. 8 , no. JUN , 384 , pp. 1-14 . https://doi.org/10.3389/fphar.2017.00384
dc.identifier.otherPURE: 12131396
dc.identifier.otherPURE UUID: b820c41f-5270-4923-b800-efdaeccf50b5
dc.identifier.otherScopus: 85021457241
dc.identifier.urihttp://hdl.handle.net/2299/21617
dc.description.abstractIntroduction: In Europe and beyond, the rising costs of healthcare and limited healthcare resources have resulted in the implementation of health technology assessment (HTA) to inform health policy and reimbursement decision-making. European legislation has provided a harmonized route for the regulatory process with the European Medicines Agency, but reimbursement decision-making still remains the responsibility of each country. There is a recognized need to move toward a more objective and collaborative reimbursement environment for new medicines in Europe. Therefore, the aim of this study was to objectively assess and compare the national reimbursement recommendations of 9 European jurisdictions following European Medicines Agency (EMA) recommendation for centralized marketing authorization. Methods: Using publicly available data and newly developed classification tools, this study appraised 9 European reimbursement systems by assessing HTA processes and the relationship between the regulatory, HTA and decision-making organizations. Each national HTA agency was classified according to two novel taxonomies. The System taxonomy, focuses on the position of the HTA agency within the national reimbursement system according to the relationship between the regulator, the HTA-performing agency, and the reimbursement decision-making coverage body. The HTA Process taxonomy distinguishes between the individual HTA agency's approach to economic and therapeutic evaluation and the inclusion of an independent appraisal step. The taxonomic groups were subsequently compared with national HTA recommendations. Results: This study identified European national reimbursement recommendations for 102 new active substances (NASs) approved by the EMA from 2008 to 2012. These reimbursement recommendations were compared using a novel classification tool and identified alignment between the organizational structure of reimbursement systems (System taxonomy) and HTA recommendations. However, there was less alignment between the HTA processes and recommendations. Conclusions: In order to move forward to a more harmonized HTA environment within Europe, it is first necessary to understand the variation in HTA practices within Europe. This study has identified alignment between HTA recommendations and the System taxonomy and one of the major implications of this study is that such alignment could support a more collaborative HTA environment in Europe.en
dc.format.extent14
dc.language.isoeng
dc.relation.ispartofFrontiers in Pharmacology
dc.subjectArchetypes
dc.subjectHealth technology assessment
dc.subjectHTA
dc.subjectNew active substances
dc.subjectPharmaceuticals
dc.subjectProcess taxonomy
dc.subjectReimbursement recommendations
dc.subjectSystem taxonomy
dc.subjectPharmacology
dc.subjectPharmacology (medical)
dc.titleA comparison of reimbursement recommendations by European HTA agencies : Is there opportunity for further alignment?en
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionUniversity of Hertfordshire
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85021457241&partnerID=8YFLogxK
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.3389/fphar.2017.00384
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record